| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 1.4 | 2.5 | 2.0 |
| Other income | 0.2 | 0.2 | 0.2 |
| Total income | 1.6 | 2.7 | 2.2 |
| Profit before exceptional items & tax | 0.1 | -0.0 | 0.1 |
| Profit before tax | 0.1 | -0.0 | 0.1 |
| Net profit | 0.1 | -0.0 | 0.0 |
| Operating margin | 6.2% | 0.0% | 4.5% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | -30.00% |
|---|
BSE results filing, BSE: 542771. Figures extracted from the filing.
Novateor Research Laboratories Ltd: key numbers
- Share price
- ₹37.50
- Market cap
- ₹22.70 Cr
- Revenue (annual)
- ₹3.83 Cr
- Net profit (annual)
- ₹0.10 Cr
- P/E (TTM)
- 224.3×Sector 42.0×
- Promoter holding
- 50.75%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Novateor Research Laboratories Ltd
All →Novateor Research Laboratories Annual Report
Novateor Research Laboratories has filed its Annual Report for the financial year 2025-26. The 15th Annual General Meeting is scheduled for September 29, 2026.
Novateor Research Laboratories Annual General Meeting
Novateor Research Laboratories Limited announced its 15th Annual General Meeting scheduled for September 29, 2026, with a cutoff date of September 25, 2026.
Novateor Research Laboratories Other Announcement
Novateor Research Laboratories Ltd has reappointed its Secretarial Auditor and Internal Auditor for the financial year 2026-27. This is a routine corporate governance compliance update.
Novateor Research Laboratories Board Meeting Outcome
Novateor Research Laboratories held a board meeting to approve auditors and scheduled its 15th AGM for September 29, 2026. The board also proposed shifting the registered office.
Novateor Research Laboratories Financial Results
Novateor Research Laboratories approved its audited standalone financial results for the year ended March 31, 2026. The results were qualified by auditors regarding inventory valuation and revenue recognition.
Novateor Research Laboratories Board Meeting Date
Novateor Research Laboratories scheduled a board meeting for May 30, 2026. Directors will consider audited financial results for the year ended March 31, 2026.